A Unique Capsule Locus in the Newly Designated Actinobacillus pleuropneumoniae Serovar 16 and Development of a Diagnostic PCR Assay by Bossé, J T et al.
A Unique Capsule Locus in the Newly
Designated Actinobacillus
pleuropneumoniae Serovar 16 and
Development of a Diagnostic PCR Assay
Janine T. Bossé,a Yanwen Li,a Rita Sárközi,b Marcelo Gottschalk,c
Øystein Angen,d Katerina Nedbalcova,e Andrew N. Rycroft,f László Fodor,b
Paul R. Langforda
Section of Paediatrics, Department of Medicine, Imperial College London, St. Mary's Campus, London, United
Kingdoma; Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest,
Hungaryb; Groupe de Recherche sur les Maladies Infectieuses du Porc, Faculté de Médecine Vétérinaire,
Université de Montréal, Montréal, Québec, Canadac; Department of Microbiology and Infection Control,
Statens Serum Institut, Copenhagen, Denmarkd; Veterinary Research Institute, Brno, Czech Republice;
Department of Pathology and Pathogen Biology, The Royal Veterinary College, Hawkshead Campus, Hatfield,
United Kingdomf
ABSTRACT Actinobacillus pleuropneumoniae causes pleuropneumonia, an economi-
cally significant lung disease of pigs. Recently, isolates of A. pleuropneumoniae that
were serologically distinct from the previously characterized 15 serovars were
described, and a proposal was put forward that they comprised a new serovar,
serovar 16. Here we used whole-genome sequencing of the proposed serovar 16
reference strain A-85/14 to confirm the presence of a unique capsular polysac-
charide biosynthetic locus. For molecular diagnostics, primers were designed
from the capsule locus of strain A-85/14, and a PCR was formulated that differ-
entiated serovar 16 isolates from all 15 known serovars and other common respi-
ratory pathogenic/commensal bacteria of pigs. Analysis of the capsule locus of
strain A-85/14 combined with the previous serological data show the existence
of a sixteenth serovar—designated serovar 16—of A. pleuropneumoniae.
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Actinobacillus pleuropneumoniae is an economically important pathogen in theswine industry, causing peracute to chronic pleuropneumonia (1, 2). Isolates can be
classified into two biovars depending on their requirement for NAD, with the majority
of isolates belonging to biovar I (require NAD for growth) and biovar II isolates (NAD
independent) less frequently identified (3). Isolates can be further differentiated into
serovars, based mainly on capsular polysaccharide (CPS) structure (3, 4). Until recently,
there were 15 recognized serovars with different geographical distributions (3, 5).
Knowing the serovar is important for epidemiological tracking as well as bacterin-based
vaccine formulation pertinent to the geographical area (3). The complete CPS biosyn-
thetic loci of these 15 serovars have been determined either specifically (6–8) or as part
of whole-genome sequence analysis (9–11). In all 15 serovars except serovar 15, the
genes of the CPS biosynthetic locus are divergently transcribed from those of the
export locus, cpxDCBA (6, 10); in serovar 15, the CPS biosynthetic genes are in the same
orientation as, and immediately precede, those of the export locus (7).
Xu et al. (10) compared the CPS loci for serovars 1 to 7 and 9 to 13 and showed that
they could be grouped into three types (see Fig. 1 for representative loci for each CPS
type), in agreement with previous structural studies (4). The loci for serovars 2, 3, 6, 7,
8, 9, 11, and 13 (type I) have a common core, with the first three genes (cps2ABC)
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sharing a high degree of identity and encoding teichoic acid transferase, glycerol
transferase, and glycerol-3-phosphate cytidylyltransferase, respectively (8, 10). The type
II CPS loci, initially identified in serovars 1, 4, and 12, share the first gene (cps1A)
encoding a CPS phosphotransferase (10), which is also seen in the subsequently
sequenced serovar 14 CPS locus (6). Although not highly conserved at the nucleotide
level, cps15A (accession no. BAR72992), the first gene in the serovar 15 CPS locus, also
encodes a CPS phosphotransferase that shares 62% identity with cps1A, suggesting that
serovar 15 also produces a type II CPS (7). In the type III capsule loci, seen in serovars
5 and 10, it is the final three genes that are common, encoding 3-deoxy-8-
phosphooctulonate synthase, 3-deoxy-manno-octulosonate cytidylyltransferase, and
arabinose-5-phosphate isomerase, respectively.
It was recently reported that five Hungarian isolates of A. pleuropneumoniae could
not be assigned to any of the known 15 serovars but rather formed a distinct
serological group, and it was proposed that they constituted a new serovar of A.
pleuropneumoniae—serovar 16 (12). Here, we used whole-genome sequencing to
determine the genetic organization of the CPS biosynthesis locus for strain A-85/14, the
proposed reference strain for serovar 16. The sequencing data show that the serovar 16
CPS locus is distinct from that of the other known 15 serovars. Furthermore, on the
basis of this unique sequence, we have designed primers for specific detection of A.
pleuropneumoniae serovar 16.
RESULTS AND DISCUSSION
The CPS biosynthetic locus for strain A-85/14 was identified as six genes, designated
cps16A to cps16F, transcribed divergently from cpxD (Fig. 1). BLASTx revealed that,
although similar sequences could be found in other bacterial species (see Table 1 and
below), including other members of the Pasteurellaceae family, these six genes are not
FIG 1 Schematic representation of the A. pleuropneumoniae serovar 16 capsule locus (proposed type IV CPS), and comparison to
representative loci for CPS types I to III. The CPS biosynthesis genes for serovar 16 (Sero 16) (cps16ABCDEF) are located downstream
of and on the opposite strand to the capsule export genes (cpxDCBA; only cpxD is shown) as in the other loci (note that although not
shown, the serovar 15 CPS biosynthetic genes are contiguous with and in the same orientation as the export genes). The relative size
and location of each gene are indicated by the sizes and positions of arrows (solid gray or patterned). For type I CPS (serovars 2, 3,
6, 7, 8, 9, 11, and 13), the locus of the serovar 2 reference strain S1536 is shown. All type I CPS loci share three common genes as
indicated by the arrows with hatching. For type II CPS (serovars 1, 4, 12, and 15), the locus for the serovar 1 reference strain 4074T
is shown. All type II loci share the first gene as indicated by the arrow with the dotted pattern. For type III CPS (serovars 5 and 10),
the locus for the serovar 5b reference strain L20 is shown. Type III CPS loci share the three kds genes indicated by the arrows
with the crosshatched pattern. The newly proposed type IV CPS locus is currently found only in serovar 16, as illustrated by the locus
of the reference strain A-85/14. The locations of serovar 16-specific primers are indicated as small curved arrows above cps16C (forward
primer AP16F) and cps16D (reverse primer AP16R).
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present in the CPS biosynthetic loci of any other serovar of A. pleuropneumoniae.
Furthermore, the arrangement of genes is not similar to that seen in any other bacterial
species sequenced thus far.
The first gene, cps16A, encodes a 261-amino-acid (aa) predicted glycosyltransferase
that shares greatest identity with the C-terminal half (82% identity for aa 198 to 458 of
465) of DcbB in Actinobacillus ureae (GenBank accession no. WP_005621190). Similar
glycosyltransferase proteins are also found in Pasteurella multocida (accession no.
WP_059246061), Avibacterium paragallinarum (GenBank accession no. ACY25522), and
Gallibacterium anatis (accession no. WP_021461679), though their exact function is not
known.
The next gene, cps16B, encodes a 565-aa protein with similarity to HyaE (34%
identity and 51% positive substitutions over the entire length; GenBank acces-
sion no. WP_010906846) involved in synthesis of the hyaluronic acid capsule of P.
multocida (13). Again, similar proteins are found in A. paragallinarum (accession no.
WP_046097317), and G. anatis (accession no. WP_065232000); with smaller proteins
(379 and 415 aa) found in strains of A. ureae (GenBank accession no. WP_044024188
and EFX92827).
The product of cps16C is a 678-aa glycosyltransferase that shows extensive similarity
to a predicted glycosyltransferase in Acinetobacter seohaensis (GenBank accession no.
SDC36622) and RfbG (dTDP-rhamnosyl transferase) from Escherichia coli (GenBank
accession no. WP_061091032). There are two predicted rhamnosyl transferase genes
(rfbF and rfbN) present in lipopolysaccharide (LPS) loci of A. pleuropneumoniae serovars
1, 9, and 11 (10), and L-rhamnose was shown to be a component of the LPS O chain in
these serovars (4). Structural studies also showed the presence of L-rhamnose in the O
chains of serovars 2, 4, 7, and 13 (4, 14), and genes encoding dTDP-4-dehydrorhamnose
reductase and dTDP-4-dehydrorhamnose 3,5-epimerase have been identified in these








(no. of aa) Bacterium % IDc Accession no. Known or putative function
Cps16A 261 DcbB 465 A. ureae 82 (91) WP_005621190 Predicted glycosyltransferase
DcbB 477 P. multocida 58 (76) WP_059246061 Predicted glycosyltransferase
CcbB 309 A. paragallinarum 58 (73) ACY25522 Predicted glycosyltransferase
479 G. anatis 57 (73) WP_021461679 Predicted glycosyltransferase
Cps16B 565 HyaE 662 P. multocida 34 (51) WP_010906846 Synthesis of hyaluronic acid capsule
542 G. anatis 34 (52) WP_065232000 Hypothetical protein
553 A. paragallinarum 33 (51) WP_046097317 Hypothetical protein
415 A. ureae 53 (71) EFX92827 Hypothetical protein
379 A. ureae 50 (69) WP_044024188 Hypothetical protein
Cps16C 678 677 A. seohaensisd 51 (69) SDC36622 Predicted glycosyltransferase
RfbG 664 E. coli 49 (68) WP_061091032 dTDP-rhamnosyl transferase
Cps16D 367 382 Haemophiluse 71 (81) WP_049357969 UDP-galactopyranose mutase
383 A. pleuropneumoniae 70 (81) WP_005613015 UDP-galactopyranose mutase
Cps16E 226 217 E. coli 57 (73) WP_024190280 Hypothetical protein
206 H. sputorum 31 (47) WP_007526031 Hypothetical protein
Cps16F 389 390 A. ureae 88 (94) WP_005621201 UDP-glucose 6-dehydrogenase
390 G. anatis 67 (14) WP_065232026 UDP-glucose 6-dehydrogenase
390 P. multocida 65 (14) AAK02860 UDP-glucose 6-dehydrogenase
aApS16 protein, protein encoded by the predicted CPS biosynthesis locus of A. pleuropneumoniae serovar 16.
bProtein names given where available. The matches with highest percent identity are listed first for each protein.
c% ID, percent identity over the matching span. Numbers in parentheses indicate the percentage of amino acids which are similar according to their physiochemical
properties over the matching span.
dA. seohaensis, Acinetobacter seohaensis.
eMultiple species of Haemophilus.
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serovars (10). However, this is the first report of L-rhamnose as a predicted component
of capsule in A. pleuropneumoniae.
Cps16D is a predicted UDP-galactopyranose mutase that is common to many
members of the Pasteurellaceae, including A. pleuropneumoniae serovars 5, 10, and 12
(GenBank accession no. WP_005613015), where it is encoded by the glf1 gene found in
the respective LPS loci (10). A different galactopyranose mutase gene, glf, is found
in the LPS loci of A. pleuropneumoniae serovars 3, 6, and 8 (10, 15). Although similar in
size, the proteins encoded by glf and glf1 share only 43% identity. The enzyme catalyzes
the conversion of UDP-galactopyranose to UDP-galactofuranose, which in turn is the
precursor of galactofuranose (Galf), a five-membered ring form of galactose found in
cell surface glycans in a variety of organisms except mammals (16). Structural studies
confirmed the presence of Galf in the LPS O chains of A. pleuropneumoniae serovars 3,
6, 8, 10, 12, 14, and 15 (4, 17, 18), but not in any of the reported CPS structures.
The cps16E gene encodes a 226-aa hypothetical protein containing a domain
indicative of coenzyme A (CoA)-dependent O-acetylation of a sugar substrate. The
protein sequence is most similar (57% identity) to a hypothetical E. coli protein
(GenBank accession no. WP_024190280), with the only detected match in the Pasteu-
rellaceae being a protein in Haemophilus sputorum (accession no. WP_007526031) with
31% identity. Structural studies identified O-acetylated sugars in the CPS of serovars 1,
8, 9, 10, and 11 (4); however, the genes predicted to encode acetyltransferases in the
CPS loci of serovars 1 (cps1D) and 10 (cps10B) (10) are distinct from cps16E, and no
acetyltransferase genes have been identified in the other CPS loci.
The final gene in the locus, cps16F, encodes a UDP-glucose 6-dehydrogenase which
is most similar (88% identity) to that found in A. ureae (GenBank accession no.
WP_005621201), with proteins in P. multocida and G. anatis (accession no. AAK02860
and WP_065232026, respectively) sharing less than 70% identity. This enzyme catalyzes
the conversion of UDP-glucose to UDP-glucuronic acid, the substrate for generation of
various surface structures, including CPS, LPS, and exopolysaccharides in a variety of
bacterial species (19).
For diagnostic purposes, we designed primers to amplify a unique 212-bp fragment
spanning the 3= end of cps16C and the 5= end of cps16D (Fig. 1). When used in
conjunction with previously designed apxIV primers for detection of all serovars of A.
pleuropneumoniae (8), the serovar 16 band was successfully amplified (along with apxIV)
from the original five isolates (12) as well as two new Hungarian isolates, but the
reference strains of A. pleuropneumoniae serovars 1 to 15 produced only the apxIV
amplicon (Fig. 2). Further testing of clinical isolates of A. pleuropneumoniae and other
bacteria associated with pigs, including publicly available genomes, confirmed the
specificity of the primers for serovar 16. Although currently identified only in Hungary,
the serovar 16-specific primers designed here will be important for wider epidemio-
logical monitoring of the distribution of this newly identified serovar. The size of the
FIG 2 Verification of specificity of primers for molecular identification of A. pleuropneumoniae serovar 16.
An apxIV (418-bp) amplicon is detected in all 16 serovar reference strains; the serovar 16-specific
amplicon (212 bp) is detected only in the serovar 16 reference strain A-85/14 and the representative
clinical isolate, 151/16. Lane M contains molecular size markers (100-bp ladder). Lanes 1 to 16 contain the
following strains: 1, 4074T; 2, S1536; 3, S1421; 4, M62; 5, L20; 6, Femo; 7, WF83; 8, 405; 9, CVJ13261; 10,
D13039; 11, 56153; 12, 8329; 13, N-273; 14, 3906; 15, HS143; 16, A-85/14. Lane 16a contains serovar 16
strain 151/16, as representative of all serovar 16 clinical isolates tested, and lane neg contains no DNA
and is a negative control.
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amplicon generated should allow these primers to be incorporated into existing
multiplex PCRs (8, 20). We did not evaluate the use of the serovar 16 primers in
quantitative PCR (qPCR).
In conclusion, we have identified the predicted capsule locus of A. pleuropneumo-
niae serovar 16 and confirmed that it is unlike that in any other serovar. Sharing no
common genes with any of the type I to III CPS loci previously identified in A.
pleuropneumoniae, it represents a new type IV locus. The combination of DNA sequence
data (this study) and serology (12) show the existence of a sixteenth serovar—
designated serovar 16—of A. pleuropneumoniae. Structural analysis of the serovar 16
capsule is under way.
MATERIALS AND METHODS
Actinobacillus pleuropneumoniae strains used in this study were as follows: the recently proposed
serovar 16 reference strain A-85/14 plus the four other strains described by Sárközi et al. (12) and two
further 2016 Hungarian isolates (151/16 and 228/16) identified as serovar 16 by serology; serovar 1 to 15
reference strains, i.e., 4074T, 1536, S1421, M62, L20, Femø, WF83, 405, CVJ13261, D13039, 56153, 8328,
N-273, 3906, and HS143, respectively (see also reference 21 for further details); and a collection of 68
clinical isolates (5 isolates each of serovars 1 to 8, 9/11, 10, 12, 14, and 15 and 3 isolates of serovar 13).
In addition, we tested 31 strains of other bacterial species associated with pigs that have been described
previously (8, 21). These strains included the type strains for Actinobacillus suis (CCM 5586T), Actinobacillus
minor (NM305T  CCUG 38923), Actinobacillus porcinus (NM319T  CCUG 38924), Actinobacillus indolicus
(46KC2T  CCUG 39029), Haemophilus parasuis (1374T  NCTC 4557), and strain CCUG 46996 for
“Actinobacillus porcitonsillarum.” Clinical isolates of Bordetella bronchiseptica and Mycoplasma hyopneu-
moniae were obtained from the Royal Veterinary College Diagnostic Laboratory and identified to the
species level by standard methods (22, 23). Pasteurella multocida porcine clinical isolates were from clonal
complex 13 as determined by multilocus sequence typing (24). Furthermore, we performed virtual PCRs
with publically available genomes for Actinobacillus ureae (3520/59T  NCTC 10219), M. hyopneumoniae
(JT  NCTC 10110), Streptococcus suis (S735T  NCTC 10234), P. multocida (n  61 including W-9217T 
NCTC 10322), B. bronchiseptica (n  68), and H. parasuis (n  212 including 1374T  NCTC 4557 [25]).
Shotgun whole-genome sequence data for A. pleuropneumoniae strain A-85/14 was generated and
assembled by the Microbes NG Sequencing Facility (www.microbesng.uk). The contig containing the
capsule locus was identified by BLASTn, using the sequence of the cpxD gene (GenBank accession no.
AIA09380) from the capsule export locus, which is common to all serovars.
Serovar 16-specific primers, AP16F (F stands for forward) (TTACTCACTTGGGCTAGGGATAG) and
AP16R (R stands for reverse) (ACCAGCAATATGATTACGCCC) were designed to amplify a 212-bp fragment
as shown in Fig. 1. These primers were initially tested for specificity using genomic DNA from the 16
reference strains (including strain A-85/14). Subsequently, the primers were combined with apxIVA1
(TTATCCGAACTTTGGTTTAGCC) and apxIVA3 (CATATTTGATAAAACCATCCGTC) that amplify a 418-bp
fragment of the species-specific apxIV gene of A. pleuropneumoniae (8) and further evaluated for
specificity using the other 101 isolates, including the negative controls. Amplification was performed
using the Qiagen Fast Cycling PCR kit, according to the manufacturer’s instructions (Qiagen). Each
reaction mixture contained 10 l Qiagen Fast Cycling PCR master mix, 2 l CoralLoad dye, 1 l genomic
DNA, each primer at a final concentration of 0.5 M, and water to a final volume of 20 l. Cycling
conditions included an initial 5-min activation at 95°C, followed by 30 cycles of PCR, with 1 cycle
consisting of denaturation at 96°C for 5 s, annealing at 60°C for 5 s, and extension at 68°C for 10 s,
followed by a final extension at 72°C for 1 min.
Accession number(s). The sequence of the complete capsule locus for serovar 16 (strain A-85/14)
has been deposited in GenBank under accession number KX907602.
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